This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Gould, M. N. Search for Related Content PubMed PubMed Citation Articles by Gould, M. N.

Inheritance and Site of Expression of Genes Controlling Susceptibility to Mammary Cancer in an Inbred Rat Model¹

Department of Human Oncology, Wisconsin Clinical Cancer Center, University of Wisconsin, Madison, Wisconsin 53792

An inbred rat model for genetically controlled susceptibility to chemically induced mammary cancer has been established. Wistar-Furth (W/Fu) rats were found to be more susceptible to 7,12-dimethylbenz(a)anthracene-induced mammary tumors than were Fischer (F344) rats. The susceptibilities of various F₁, F₂, and backcross generations of these strains were examined for susceptibility to 7,12-dimethylbenz(a)anthracene-induced mammary tumors. The data suggest that susceptibility is inherited as a dominant trait. Both a single locus autosomal model and an X-linked model have been ruled out. However, the data support the hypothesis that complete susceptibility is controlled by any one of a group of independently segregating genes; i.e., any one gene of this group is both necessary and sufficient to induce maximal susceptibility. It is not known if these genes are identical or different. In order to identify the role of these genes we asked if they were expressed in the mammary epithelial cells themselves or elsewhere in the rat. Chimeric animals were produced by transplanting mammary cells from either W/Fu or F344 rats into the white interscapular fat pad of female W/Fu x F344 F₁ rats. One month after transplantation the animals were treated with 7,12-dimethylbenz(a)anthracene and then palpated weekly for tumor development at the graft site. Tumors developed more rapidly and in greater total frequency at sites grafted with W/Fu mammary cells. This result suggests that the genes controlling inherited susceptibility are expressed in the mammary cells. The role of these genes is now under investigation. We have thus far shown that they do not control carcinogen metabolism or activation.

¹ Supported by Grant CA28954 from the National Cancer Institute, NIH, Department of Health and Human Services.

Received 9/ 9/85. Revised 11/19/85. Accepted 11/22/85.

This article has been cited by other articles:

				X. Ren, X. Zhang, A. S. Kim, A. M. Mikheev, M. Fang, R. C. Sullivan, R. E. Bumgarner, and H. Zarbl Comparative genomics of susceptibility to mammary carcinogenesis among inbred rat strains: role of reduced prolactin signaling in resistance of the Copenhagen strain Carcinogenesis, January 1, 2008; 29(1): 177 - 185. [Abstract] [Full Text] [PDF]

				D. J. Samuelson, J. D. Haag, H. Lan, D. M. Monson, M. A. Shultz, B. D. Kolman, and M. N. Gould Physical evidence of Mcs5, a QTL controlling mammary carcinoma susceptibility, in congenic rats Carcinogenesis, September 1, 2003; 24(9): 1455 - 1460. [Abstract] [Full Text] [PDF]

				G. A. Wood, J. E. Korkola, and M. C. Archer Tissue-specific resistance to cancer development in the rat: phenotypes of tumor-modifier genes Carcinogenesis, January 1, 2002; 23(1): 1 - 9. [Abstract] [Full Text] [PDF]